Because of the growing prevalence of cancer survivorship, the financial burden of cancer is becoming increasingly overwhelming for patients not only immediately after a cancer diagnosis, but often many years after treatment, said K. Robin Yabroff, PhD, MBA, of the American Cancer Society.
According to findings from a national representative sample presented at the 2018 Cancer Survivorship Symposium, fear of cancer recurrence is prevalent among cancer survivors, but may only be experienced by a minority of patients.
The American Society of Clinical Oncology and the National Comprehensive Cancer Network collaborated to jointly develop a new guideline to help clinicians recognize and manage the range of side effects from immune checkpoint inhibitors.
August 2026 | Volume 19 | No 3
To sign up for our newsletter or print publications, please enter your contact information below.
